Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
| Revenue (Most Recent Fiscal Year) | $2.11B |
| Net Income (Most Recent Fiscal Year) | $404.39M |
| PE Ratio (Current Year Earnings Estimate) | 38.98 |
| PE Ratio (Trailing 12 Months) | 40.31 |
| PEG Ratio (Long Term Growth Estimate) | 2.17 |
| Price to Sales Ratio (Trailing 12 Months) | 6.89 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 55.30 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 41.32 |
| Pre-Tax Margin (Trailing 12 Months) | 22.02% |
| Net Margin (Trailing 12 Months) | 18.36% |
| Return on Equity (Trailing 12 Months) | 91.88% |
| Return on Assets (Trailing 12 Months) | 23.65% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.57 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.57 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $26.56 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.86 |
| Earnings per Share (Most Recent Fiscal Year) | $12.63 |
| Diluted Earnings per Share (Trailing 12 Months) | $14.30 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 28.17M |
| Free Float | 22.45M |
| Market Capitalization | $16.24B |
| Average Volume (Last 20 Days) | 0.25M |
| Beta (Past 60 Months) | 1.43 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 77.98% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |